CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-19 | GORMAN KEVIN CHARLES Director | Option exercise 10b5-1 | +205,088 | $43.24 | $8.9M | 756,381 |
| 2026-05-19 | GORMAN KEVIN CHARLES Director | Sale 10b5-1 | −245,088 | $154.33 | $37.8M | 511,293 |
| 2026-05-19 | GORMAN KEVIN CHARLES Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −205,088 | 0 | ||
| 2026-05-15 | POPS RICHARD F Director | Option exercise 10b5-1 | +15,000 | $47.89 | $718K | 49,480 |
| 2026-05-15 | POPS RICHARD F Director | Sale 10b5-1 | −15,000 | $157.65 | $2.4M | 34,480 |
| 2026-05-15 | POPS RICHARD F Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −15,000 | 0 | ||
| 2026-05-12 | Norwalk Leslie V Director | Sale 10b5-1 | −3,810 | $155.01 | $591K | 2,429 |
| 2026-03-04 | ABERNETHY MATT Chief Financial Officer | Gift | −2,249 | 42,808 | ||
| 2026-02-20 | Onyia Jude Chief Scientific Officer | Gift | −3,110 | 25,670 | ||
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise | +1,401 | 7,176 | ||
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Shares withheld for taxes | −756 | $124.12 | $94K | 6,420 |
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise | +1,359 | 7,779 | ||
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Shares withheld for taxes | −734 | $124.12 | $91K | 7,045 |
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Grant or award | +19,935 | 26,980 | ||
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Shares withheld for taxes | −10,755 | $124.12 | $1.3M | 16,225 |
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Restricted Stock Unit | −1,401 | 2,802 | ||
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Restricted Stock Unit | −1,359 | 1,359 | ||
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Grant or award · Stock Option | +31,234 | 31,234 | ||
| 2026-02-13 | Delaet Ingrid Chief Regulatory Officer | Grant or award · Restricted Stock Unit | +5,479 | 5,479 | ||
| 2026-02-13 | Boyer David W. Chief Corp. Affairs Officer | Option exercise | +1,541 | 6,990 |
Page 8 of 37 · 740 trades